Bull
$7.77
シナリオ価格
$12.180
+0.019 (+0.16%)終値時点
Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA. It sells a variety of weight loss, weight management and healthy living products all based on its proprietary formulas under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories. Its product line includes approximately 74 consumable options, including, but not limited to, bars, cereal, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. Its OPTAVIA ASCEND mini meals deliver nutrition that gives clients’ bodies what they need to - whether losing weight on a GLP-1 medication or in weight management mode. Its OPTAVIA Fuelings contain approximately 24 vitamins and minerals, high quality, complete protein, and no colors, flavors or sweeteners from artificial sources.
Medifast Inc is a good buy right now due to its recent earnings performance and positive growth outlook. The current price is $12.18, with a forward P/E ratio of 12.48, indicating potential for future earnings growth. Additionally, the company reported a 34.29% price change following its last earnings announcement, reflecting strong investor confidence. However, the main risk is the projected loss per share of $0.35 for Q3 2026, which could impact investor sentiment.
Stephens
$12
2026-02-19
Stephens
2026-02-19
目標株価
$12
DA Davidson
$17
2025-02-19
DA Davidson
2025-02-19
目標株価
$17
DA Davidson
$17
2024-11-05
DA Davidson
2024-11-05
目標株価
$17
DA Davidson
$18
2024-07-22
DA Davidson
2024-07-22
目標株価
$18
DA Davidson
$18
2024-06-05
DA Davidson
2024-06-05
目標株価
$18
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Medifast Launches Metabolic Health Institute to Enhance Wellness

Medifast (MED) Q2 2026 Earnings Call Transcript

Medifast Shares Surge 32% on Strong Q2 Results Exceeding Expectations

Medifast Q2 2026 Earnings Call Insights

Medifast Q2 Earnings Report Preview
Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA. It sells a variety of weight loss, weight management and healthy living products all based on its proprietary formulas under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories. Its product line includes approximately 74 consumable options, including, but not limited to, bars, cereal, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. Its OPTAVIA ASCEND mini meals deliver nutrition that gives clients’ bodies what they need to - whether losing weight on a GLP-1 medication or in weight management mode. Its OPTAVIA Fuelings contain approximately 24 vitamins and minerals, high quality, complete protein, and no colors, flavors or sweeteners from artificial sources. It operates in the Consumer Non-Cyclicals sector (MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS industry).
Medifast Inc is a good buy right now due to its recent earnings performance and positive growth outlook. The current price is $12.18, with a forward P/E ratio of 12.48, indicating potential for future earnings growth. Additionally, the company reported a 34.29% price change following its last earnings announcement, reflecting strong investor confidence. However, the main risk is the projected loss per share of $0.35 for Q3 2026, which could impact investor sentiment.
2 analysts cover MED: 1 rate it Buy, 1 Hold and 0 Sell.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。